These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1777981)

  • 1. Urinary oligosaccharide excretion and severity of galactosialidosis and sialidosis.
    Takahashi Y; Nakamura Y; Yamaguchi S; Orii T
    Clin Chim Acta; 1991 Dec; 203(2-3):199-210. PubMed ID: 1777981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of sialyloligosaccharides isolated from sialidosis and galactosialidosis urine.
    Van Pelt J; Kamerling JP; Bakker HD; Vliegenthart JF
    J Inherit Metab Dis; 1991; 14(5):730-40. PubMed ID: 1779619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe infantile sialidosis--the characteristics of oligosaccharides isolated from the urine and the abdominal ascites.
    Nakamura Y; Takahashi Y; Yamaguchi S; Omiya S; Orii T; Yara A; Gushiken M
    Tohoku J Exp Med; 1992 Apr; 166(4):407-15. PubMed ID: 1502687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary oligosaccharide excretion in nephrotic syndrome.
    Takahashi Y; Omiya S; Nakamura Y; Kondo N; Orii T
    Pediatr Res; 1993 Oct; 34(4):429-34. PubMed ID: 8255672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan profiling of urine, amniotic fluid and ascitic fluid from galactosialidosis patients reveals novel oligosaccharides with reducing end hexose and aldohexonic acid residues.
    Bruggink C; Poorthuis BJ; Piraud M; Froissart R; Deelder AM; Wuhrer M
    FEBS J; 2010 Jul; 277(14):2970-86. PubMed ID: 20546307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of GM1 gangliosidosis and urinary oligosaccharide excretion.
    Takahashi Y; Orii T
    Clin Chim Acta; 1989 Feb; 179(2):153-62. PubMed ID: 2493350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a protocol for the detection of disorders of sialic acid metabolism to 124 high-risk Brazilian patients.
    Castilhos CD; Mello AS; Burin MG; Guidobono RR; Gotardo S; Giugliani R; Coelho JC
    Am J Med Genet A; 2003 Jun; 119A(3):348-51. PubMed ID: 12784303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligosaccharide analysis in urine by maldi-tof mass spectrometry for the diagnosis of lysosomal storage diseases.
    Xia B; Asif G; Arthur L; Pervaiz MA; Li X; Liu R; Cummings RD; He M
    Clin Chem; 2013 Sep; 59(9):1357-68. PubMed ID: 23676310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thin-layer chromatography of urine oligosaccharides in diagnosis of some lysosomal storage disorders].
    Lugowska A; Tylki-Szymańska A; Sawnor-Korszyńska D
    Pediatr Pol; 1995 Oct; 70(10):847-55. PubMed ID: 8649932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC-MS/MS Analysis of Urinary Free Oligosaccharides for Lysosomal Storage Diseases: Diagnosis and Potential Treatment Monitoring.
    Huang R; Cathey S; Pollard L; Wood T
    Clin Chem; 2018 Dec; 64(12):1772-1779. PubMed ID: 30201803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the accumulated sialic acid-containing oligosaccharides from cultured human galactosialidosis and sialidosis fibroblasts.
    van Pelt J; Kamerling JP; Vliegenthart JF; Hoogeveen AT; Galjaard H
    Clin Chim Acta; 1988 Jun; 174(3):325-35. PubMed ID: 3134148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemistry and clinical features of galactosialidosis.
    Okamura-Oho Y; Zhang S; Callahan JW
    Biochim Biophys Acta; 1994 Feb; 1225(3):244-54. PubMed ID: 8312369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical heterogeneity in infantile galactosialidosis.
    Sewell AC; Pontz BF; Weitzel D; Humburg C
    Eur J Pediatr; 1987 Sep; 146(5):528-31. PubMed ID: 3119343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of urinary oligosaccharides in lysosomal storage disorders by capillary high-performance anion-exchange chromatography-mass spectrometry.
    Bruggink C; Poorthuis BJ; Deelder AM; Wuhrer M
    Anal Bioanal Chem; 2012 Jun; 403(6):1671-83. PubMed ID: 22526647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligosaccharides in (galacto)sialidosis urine.
    vanPelt J
    Clin Chim Acta; 1992 Jun; 208(3):231-2. PubMed ID: 1499142
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses.
    Piraud M; Pettazzoni M; Menegaut L; Caillaud C; Nadjar Y; Vianey-Saban C; Froissart R
    Rapid Commun Mass Spectrom; 2017 Jun; 31(11):951-963. PubMed ID: 28370531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic advances in galactosialidosis].
    Hirasawa M
    Nihon Rinsho; 1993 Sep; 51(9):2319-23. PubMed ID: 8411708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Storage of sialic acid-containing carbohydrates in the placenta of a human galactosialidosis fetus. Isolation and structural characterization of 16 sialyloligosaccharides.
    Van Pelt J; Van Kuik JA; Kamerling JP; Vliegenthart JF; Van Diggelen OP; Galjaard H
    Eur J Biochem; 1988 Nov; 177(2):327-38. PubMed ID: 3142773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Juvenile galactosialidosis with attacks of neuropathic pain and absence of sialyloligosacchariduria.
    Darin N; Kyllerman M; Hård AL; Nordborg C; Månsson JE
    Eur J Paediatr Neurol; 2009 Nov; 13(6):553-5. PubMed ID: 19097920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of a reduced amount of 32-kd "protective" protein is a distinct biochemical finding in late infantile galactosialidosis.
    Strisciuglio P; Parenti G; Giudice C; Lijoi S; Hoogeveen AT; d'Azzo A
    Hum Genet; 1988 Nov; 80(3):304-6. PubMed ID: 3142815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.